The Make Medicines Affordable (MMA) podcast delves into medicine equity. Through expert insights, analysis, and firsthand accounts from around the world, exploring ways to end unfair pharmaceutical monopolies on life-saving health products.
In the first episode, MMA explore the pressing need for enhanced HIV prevention options worldwide, discussing the potential of cabotegravir, a long-acting, injectable method of HIV prevention which is also called CAB-LA.
Their guests, Dr. Andrew Hill from the University of Liverpool, and Susana van der Ploeg from Brazil’s Interdisciplinary AIDS Association (ABIA), discuss the global need for, and efficacy of long-acting and oral HIV prevention, and perspectives on access barriers.
You can learn more about Long-Acting Injectables for HIV below.
Long-Acting HIV Treatment
FAQs
